Skip to main content
Premium Trial:

Request an Annual Quote

LifeSpan Licenses DrugTarget Database to Undisclosed Pharma

NEW YORK, Aug. 23 (GenomeWeb News) - LifeSpan BioSciences said today that it has licensed its DrugTarget database to an undisclosed pharmaceutical company, marking the 50th database license the company has issued.


According to the company, the database contains proprietary human protein localization data for drug targets in eight gene families, including G protein-coupled receptors, nuclear hormone receptors, kinases, ion channels, phosphatases, proteases, phosphodiesterases, and transporters.


Under the new licensing agreement, the subscriber will nominate 50 additional genes for study and inclusion in the expanded database over a two-year period. It already includes 822 immunohistochemistry reports with localization information on more than 400 potential drug target genes selected by subscribers, said LifeSpan. The expanded database will include ion channels, secreted proteins, phosphatases, and other families of genes.


Additional terms of the license were not disclosed.


The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.